Stay updated on ACTIV-2 Outpatient COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTIV-2 Outpatient COVID-19 Clinical Trial page.

Latest updates to the ACTIV-2 Outpatient COVID-19 Clinical Trial page
- CheckyesterdayChange DetectedThe study’s publication list now includes two additional 2024 journal articles on monoclonal antibody treatment and memory B-cell responses. The FDA Safety Alerts and Recalls resource link was removed, and the record revision changed to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page displays the ACTIV-2 outpatient COVID-19 study record, including its treatments, eligibility criteria, outcomes, locations, and supporting documents.SummaryDifference100%

- Check22 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces an NIH terminology transition, noting that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check36 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2. The study record still displays a 403 error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.SummaryDifference0.2%

Stay in the know with updates to ACTIV-2 Outpatient COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIV-2 Outpatient COVID-19 Clinical Trial page.